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Abstract
Background: Resveratrol is a non flavonoid polyphenol compound present in many plants and fruits and,
at especially high concentrations, in the grape berries of Vitis vinifera. This compound has a strong
bioactivity and its cytoprotective action has been demonstrated, however at high concentrations the drug
exhibits also an effective anti-proliferative action. We recently showed its ability to abolish the effects of
oxidative stress in cultured cells. In this work we assayed the bioactivity of resveratrol as antiproliferative
and antiviral drug in cultured fibroblasts. Studies by other Authors showed that this natural compound
inhibits the proliferation of different viruses such as herpes simplex, varicella-zoster and influenza A. The
results presented here show an evident toxic activity of the drug at high concentrations, on the other hand
at sub-cytotoxic concentrations, resveratrol can effectively inhibit the synthesis of polyomavirus DNA. A
possible interpretation is that, due to the damage caused by resveratrol to the plasma membrane, the
transfer of the virus from the endoplasmic reticulum to the nucleus, may be hindered thus inhibiting the
production of viral DNA.
Methods: The mouse fibroblast line 3T6 and the human tumor line HL60 were used throughout the
work. Cell viability and vital cell count were assessed respectively, by the MTT assay and Trypan Blue
staining. Cytotoxic properties and evaluation of viral DNA production by agarose gel electrophoresis
were performed according to standard protocols.
Results: Our results show a clear dose dependent both cytotoxic and antiviral effect of resveratrol
respectively at high and low concentrations. The cytotoxic action is exerted towards a stabilized cell-line
(3T6) as well as a tumor-line (HL60). Furthermore the antiviral action is evident after the phase of virion
entry, therefore data suggest that the drug acts during the synthesis of the viral progeny DNA.
Conclusion:  Resveratrol is cytotoxic and inhibits, in a dose dependent fashion, the synthesis of
polyomavirus DNA in the infected cell. Furthermore, this inhibition is observed at non cytotoxic
concentrations of the drug. Our data imply that cyto-toxicity may be attributed to the membrane damage
caused by the drug and that the transfer of polyomavirus from the endoplasmic reticulum to the cytoplasm
may be hindered. In conclusion, the cytotoxic and antiviral properties of resveratrol make it a potential
candidate for the clinical control of proliferative as well as viral pathologies.
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Background
Murine polyomavirus (Py) is an ideal model system to
investigate many different biological phenomena at cellu-
lar and molecular level. Polyomavirus is totally depend-
ent on the metabolism of the infected cell: therefore, it has
been used to study cellular and molecular functions. Clas-
sical works based on the study of the viral proliferation
helped to elucidate the mechanisms of the regulation of
DNA replication, RNA transcription and translation as
well as tumor transformation. Analogously to other poly-
omaviruses, with which it shares a high sequence homol-
ogy, Py can very efficiently transform non permissive cells
in culture and is able to cause tumors if injected in
immuno-suppressed or singeneic animals (see: [1] for a
compendium on polyomaviruses and [2-7] for more
recent reviews on this subject).
In last decade we investigated the role of both natural and
synthetic substances on Py DNA replication and RNA
transcription [8-10]. Also, the cellular and metabolic
response after exposure to these substances was studied
[11-15]. We particularly focused our attention on a natu-
ral complex mixture, known as MEX, obtained by meth-
anolic extraction of whole neem oil [13]. This oil is
prepared from the seeds of Azadirachta indica and has
been extensively used in Ayurveda, Unani and Homoeo-
pathic medicine possibly for centuries [16,17]. In our lab-
oratory MEX showed a significant and differential
cytotoxic action, with the cancer cells being more sensitive
than the normal ones [18]. The main target of MEX is the
plasma membrane which, after treatment with this
extract, becomes more fluid without a substantial loss of
its structural properties [19]. In addition, preliminary
experiments performed in our laboratory suggest that
MEX has also an antiviral activity (Berardi et al., in prepa-
ration); in any case a similar activity of neem leaf extracts
was reported in a model of Dengue virus [20].
In this work we assayed the action of resveratrol (RV), a
natural compound raising an increasing interest on the
proliferation of cultured cells i.e.: the murine fibroblast
line 3T6 as well as in the tumor line HL60. In addition, we
also investigated the action of this drug on the prolifera-
tion of the murine polyomavirus in the infected cell pop-
ulation.
Resveratrol is a non-flavonoid polyphenol compound
present in many plants and fruits, at especially high con-
centrations in the grape berries of Vitis vinifera [21]. This
compound has a high bioactivity and its cytoprotective
action has been demonstrated. As a matter of fact, possi-
bly due to its polyphenol characteristics, RV was also
shown to have antiviral action versus influenza A [22] and
varicella zoster virus in cultured cells [23]. Analogous
properties of RV against Herpes virus simplex I were
shown in animal models [24]. In this latter case, suppres-
sion of transcription factor NF-κ-B seems to be involved in
its antiviral property [25].
The results presented here show that RV exhibits a cyto-
toxic activity and has an antiviral property since it effi-
ciently inhibits the synthesis of Py DNA. The inhibition is
observed at non cyto-toxic concentrations of RV as shown
by vital cell count and quantitative evaluation of the viral
DNA synthesis after exposure to the drug. In addition, our
results evidence a clear dose dependent antiviral effect of
resveratrol. Since this action appears after the phase of vir-
ion penetration, data suggest that resveratrol exerts its
antiviral properties during the synthesis of the viral DNA
progeny. However because of its cytotxic properties, it
may be envisaged an application of RV to control nega-
tively the cell growth in proliferative diseases.
Methods
Cell cultures
The mouse fibroblast line 3T6 and the tumor line HL60
were used throughout the work. Cells were grown in high
glucose DMEM, supplemented with newborn bovine
serum (10% final concentration) glutamine (50 mM) and
penicillin-streptomycin (10000 U/mL). Growth tempera-
ture was 37°C in controlled humidity at 5% CO2. Cells
were routinely split and sub-cultured every third day.
Viral infection was performed at 4 pfu × cell-1, for 2 hours
at 37° with occasional rocking. Infection procedure and
extraction (replication assays) of de novo synthesized DNA
were described in detail in previous works, see for instance
[9,10,26]. Viral DNA was visualized after agarose gel elec-
trophoresis in the presence of ethidium bromide (0.5 μg/
ml, final concentration). Evaluation of cell vitality: Cell
viability was assessed by the colorimetric MTT assay [27].
Absorbance was measured at 570 nm to obtain a standard
cell count. The number of cells surviving to the treatment
with RV (20 μM) was also evaluated by vital cell count in
Trypan Blue in a Burker chamber. The same approach was
adopted to count the cell mortality consequent to Py
infection [18].
All experiments were repeated at least three times. The
error bars indicate the Standard Deviation of the Mean (±
SEM).
Results
Evaluation of the cytotoxicity of resveratrol and of the cell 
death consequent to Py infection
In preliminary experiments we assessed the concentration
at which RV may exert a putative cytotoxic activity. It
should pointed out, as a matter of fact, that natural sub-
stances endowed of cytoprotective and antioxidant prop-
erties, may present a threshold effect above which theyJournal of Experimental & Clinical Cancer Research 2009, 28:96 http://www.jeccr.com/content/28/1/96
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can paradoxically show cytotoxic properties. The phe-
nomenon has been documented for RV and its analogues
as well as for curcumin another potent antioxidant drug
with cytoprotective features [28-31].
The cytotoxicity of RV on 3T6 cells has been evaluated by
the Mossman assay [27] after treatment for 24 and 48
hours (Figure 1A and 1B, respectively), but in this latter
case the treatment with 2 μM RV was omitted since this at
this concentration the drug does not have a significant
effect on cell mortality. The drug is dissolved in 0.02%
DMSO (final concentration) in PBS but, at this low con-
centration, the organic solvent has no effects on cell sur-
vival, as shown by the second bar from the left. However
cells exposed to RV at the concentrations of 20 and 40 μM
show some sensitivity to the drug, since only about 60%
of the cell population survives the treatment for 48 hours
at the higher concentration. The vital cell count observed
after trypan blue staining is in good agreement with the
one obtained by the Mossman assay (Table 1, only the
data for 20 μM RV at after 24 hour of treatment are
shown).
We also investigated the cytotoxic activity of RV on the
tumor cells HL60: a human promyelocytic leukemia cell
line. The results clarly show that RV can significantly
inhibit the cell growth already at a concentration of 25
μM.
Subsequently we assessed the level of cell mortality
induced by Py infection: in this case we used the method
of vital cell staining only with trypan blue. As a matter of
fact, the MTT assay is informative of cell death deriving
from membrane damage and former data from our labo-
ratory indicated that the plasma membrane is actually one
of the targets of RV. On the contrary, trypan blue staining
has a more general action ranging from a generic damage
of cell membrane to severe problems in cell homeostasis.
Table 2 reports the vital cell counts in control and Py
infected cells.
The reported data show that after 48 hours of infection the
cell death rate is about as double as in controls: however
the viral infection does not seem to cause extensive loss
cell vitality.
In the light of these results the effect of RV on Py prolifer-
ation was evaluated at 24 hours post-infection in cells
were treated with 20 μM RV or at the concentrations of
drug reported in the legends to the figures.
Effect of resveratrol on the viral proliferation
Semi-confluent cells were infected with Py and RV was
added after the absorption phase at the indicated final
concentrations. Infection was continued for 24 hours and
progeny viral DNA was extracted according to the Hirt-
procedure [26] (Figure 2A). The data clearly show that the
viral replication is virtually abrogated at 20 μM RV. Infec-
tions performed in the presence of RV during the absorp-
tion phase gave essentially the same results (not shown).
To assess whether the continuous presence of RV is neces-
sary to inhibit the viral replication we removed the drug at
different time points after the viral penetration into the
cell (Figure 3). Therefore, the infection was carried out in
20 μM RV but the culture medium was changed to a drug-
free fresh medium after different times of treatment and
the incubation was continued for 24 hours. Results show
that removal of RV after four hour incubation has little or
no effect on the yield of viral progeny DNA (lane 2). The
drug must be present for the whole infection time to be
effective and to cause the complete inhibition of the viral
replication (lanes 6 and 7).
Discussion
In this work we report on cytotxicity versus two different
cell lines: a normal mouse firbroblast line and tumoral
one. The results clearly show that RV can exert a cytotoxic
action both against a normal stabilized fibroblast cell line
and human tumor cells. The human tumor line seems to
be slightly more sensitive to the drug and this recalls
results previously obtained in our laboratory with MEX: a
partially purified natural mixture [18]. The antiviral activ-
ity of resveratrol towards murine polyomavirus infection
was also evaluated. The exposure to the drug was carried
at a concentration of RV which did not show a significant
cytotoxic effect. It is known that resveratrol can exert anti-
oxidant and anti-inflammatory activities and, also, it reg-
ulates multiple cellular events associated with carcinogen-
esis: for a relatively recent review see [28]. The cytotoxicity
of RV is only apparently paradoxical; as a matter of fact
this drug induces cell cycle arrest and stimulates the Reac-
tive Oxygen Species (ROS) activated mitochondrial path-
way leading to apoptosis [29,30]. An analogous
paradoxical action has been described for another potent
antioxidant: curcumin, which is able to induce apoptosis
in human cervical cancer cells [31]. Therefore, an evalua-
tion of possible cytotoxic effects of RV in our model sys-
Table 1: Vital cell count after trypan blue staining of cells treated 
with resveratrol (20 μM) for 24 hours.
RV – Treated 3T6 Cells
Sample Vital Non-Vital
12 7 3
23 2 2
32 8 3
43 0 3
Average cell mortality 8.7 ± 2.6%Journal of Experimental & Clinical Cancer Research 2009, 28:96 http://www.jeccr.com/content/28/1/96
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tem was a necessary pre-requisite. Murine polyomavirus
productive cycle ends with the lysis of the infected cell:
hence the actual number of cells dying as a consequence
of viral proliferation had to be also assessed. The results of
these experiments allowed us to find out the best condi-
tions where the putative antiviral activity on murine Py
could be investigated.
The results presented in this work show that like in the
case of influenza A, HVS and varicella-zoster [22-25], the
viral replication is severely inhibited by RV also in the case
of murine Py. The inhibition is dose and time dependent
and all experiments were carried out at 24 hour of infec-
tion time when the effects on the cell viability due to the
exposure to the drug or to the viral proliferation are min-
imal. Similar results were obtained after 42 hours of infec-
tion but after such a prolonged time the significant cell
mortality induced by RV and by the progression of the
viral infection could overlap and/or mask the actual
effects attributable to the drug (infection data non
shown). Furthermore infection experiments performed in
the presence of RV during the absorption phase gave
essentially the same results obtained in infections experi-
ments where drug was added after the viral penetration
(not shown). This strongly suggests that virus entry is not
the main target of RV whose action is therefore exerted
during the phase of viral DNA synthesis. Furthermore, the
presence of the drug for the whole duration of the infec-
tion is necessary to abrogate completely the viral DNA
production. As a mater of fact exposure to the drug for
Cytotoxicity of resveratrol assessed by the Mossman assay Figure 1
Cytotoxicity of resveratrol assessed by the Mossman assay. The bars report the percentage of viable cells after differ-
ent times of exposure to the drug (24 hours: four bars to the left; 48 hours two bars to the right). The untreated control and 
the sample in DMSO at 48 hour are omitted since the data are virtually identical to the ones obtained at 24 hours. Data 
reported in upper panel refer to 3T6 cells while those shown in the lower panel refer to HL60 cells.Journal of Experimental & Clinical Cancer Research 2009, 28:96 http://www.jeccr.com/content/28/1/96
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Table 2: Assessment of the cell mortality rate due to Py proliferation.
Virus Py 24 h
Sample Vital Non-Vital
1 44 1
2 45 2
3 41 2
4 52 1
Average cell mortality 3,4% ± 1,5%
Virus Py 48 h
Sample Vital Non-Vital
1 40 2
2 46 4
3 44 4
4 49 2
Average cell mortality 6,7% ± 2,5%
The vital cell count was evalutated by trypan blue staining.
Viral DNA yield obtained at 24 hours post-infection Figure 2
Viral DNA yield obtained at 24 hours post-infection. Left panel: Electropherogram of the de novo synthesized progeny 
viral DNA (form I) indicated by the arrow. Lane 1: Mock infected cells, Lane 2: Untreated control cells; Lane 3 and 4: Cells 
treated with RV 20 μM and 40, respectively. Right panel: Quantification of the fluorescence bands reported in the left panel. 
The yield of the viral DNA is normalized to the amount obtained in untreated control cells (Bar 1). Bar 3 and bar 4: viral DNA 
obtained after treatment with RV 20 μM and 40, respectivelyJournal of Experimental & Clinical Cancer Research 2009, 28:96 http://www.jeccr.com/content/28/1/96
Page 6 of 7
(page number not for citation purposes)
shorter time has no effect on the overall yield of viral
DNA. Incidentally, this data also shows that the intracel-
lular "life time" of the viral DNA is fairly long, since
removal of the drug after 12 hours exposure seems to have
little effect on the amount of the progeny DNA. These data
recall a similar observation made in our laboratory with a
different natural substance [9].
At the moment the mechanism of action of RV remains to
be elucidated; however in the case of influenza A virus, the
translocation of viral ribo-nucleoprotein complexes to the
endoplasmic reticulum is hindered and the expression of
late viral proteins is reduced. These two phenomena could
be related to the inhibition of protein kinase C activity
and its dependent pathways [22]. Also, Py utilizes protein-
protein complexes associated to the endoplasmic reticu-
lum and involving the viral capsid proteins VP2 and VP3
[32]. Therefore it could be speculated that the viral trans-
fer to the nucleus, in the case of Py, follows an analogous
process.
Conclusion
The results presented in this work demonstrate a clear,
dose dependent cytotoxic and antiviral effect of resvera-
trol: cytotoxicity at high concentration of the drug both on
normal and tumor cells. On the other hand at low concen-
tration, the continuous presence in the culture medium is
necessary for the drug to be effective. The target of RV is
the replication of viral DNA; however further studies are
required for the full elucidation of the inhibitory mecha-
nism mediated by RV leading to the abrogation of the
viral DNA synthesis. This effect was demonstrated in the
absence of significant cytotoxic effects induced by the
drug. Removal of RV at short time after infection does not
have a significant effect on the production of viral progeny
DNA and this suggests that the viral penetration is not the
main target of the drug. Therefore we may conclude that
the RV dependent inhibition of the viral proliferation
occurs at subsequent stages: possibly during translocation
of the virion from cytoplasm to nucleus.
Finally this work gives a further support to the possibility
that RV may find a potential clinical use for the control of
proliferative pathologies and/or as an antiviral drug.
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Decrease of viral DNA as a function of the duration of the exposure to resveratrol Figure 3
Decrease of viral DNA as a function of the duration of the exposure to resveratrol. Left panel: Progeny viral DNA 
(form I) is indicated by the arrow. In this case, the culture medium was changed to fresh drug-free medium at the following 
times post-infection. The incubation was continued for 24 hours. Lane 1: Mock infected cells; Lane 2: Untreated control cells; 
Lane 3 through 6: 4, 8, 12 and 16 hours, respectively; Lane 7: The medium was not changed and infection was carried perma-
nently in the presence of RV (20 μM). Right panel: Quantification of the fluorescence bands reported in the left panel. The yield 
of the viral DNA is normalized to the amount obtained in untreated control cells (Bar 1). Withdrawal of RV is reported in the 
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